| Jewish Social Service Agency Hospice 1309 Piccard Dr #201, Rockville, MD, 20850 | |
| (301) 881-3700 |
News Archive
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.
Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.
› Verified 2 days ago
| Name | Jewish Social Service Agency Hospice |
|---|---|
| Location | 1309 Piccard Dr #201, Rockville, Maryland |
| Hospice ID | 211508 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 150 |
News Archive
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.
Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.
› Verified 2 days ago
| NPI Number | 1194832261 |
| Organization Name | Jewish Social Service Agency |
| Address | 1390 Piccard Dr Rockville, Maryland, 20850 |
| Phone Number | (301)881-3700 |
News Archive
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.
Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.6 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 97.4 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 95.4 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 48.3 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 99.3 | 93.3 |
News Archive
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.
Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.
› Verified 2 days ago
| Home Health Aides | 6.5 |
| Counselors | 1.5 |
| Medical Social Workers | 3.6 |
| Physicians | 0.25 |
| Registered Nurses | 15.85 |
| Other Personnel | 5 |
| Total Employees | 32.7 |
|---|
News Archive
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.
Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.
› Verified 2 days ago
| Others | 126 |
| Total Volunteers | 126 |
|---|
News Archive
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants.
Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
Palisade Systems, the leader In Data Loss Prevention solutions for the small- and medium-sized enterprise, today announces that Cincinnati-based Secure Content Technologies has joined its VIP Reseller Program. As a reseller, Secure Content Technologies will market Palisade Systems PacketSure solution to the small and medium enterprise market seeking a full data loss prevention solution for the various markets including the healthcare, educational and financial sectors.
› Verified 2 days ago
| Montgomery Hospice Inc Location: 1355 Piccard Drive, Suite 100, Rockville, Maryland, 20850 Phone: (301) 881-3700 |
| Jewish Social Service Agency Hospice Location: 1309 Piccard Dr #201, Rockville, Maryland, 20850 Phone: (301) 881-3700 |